Surgery of Early-Stage Pancreatic Cancer Available to Purchase

2.

Vincent

A

,

Herman

J

,

Schulick

R

,

Hruban

RH

,

Goggins

M

.

Pancreatic cancer

.

Lancet

.

2011

;

378

(

9791

):

607

–

20

.

3.

SEER Cancer Statistics Review

. SEER. 1975-2018 Available from: https://seer.cancer.gov/csr/1975_2018/index.html (accessed 5 November 2024).

4.

Blackford

AL

,

Canto

MI

,

Klein

AP

,

Hruban

RH

,

Goggins

M

.

Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis

.

J Natl Cancer Inst

.

2020

;

112

(

11

):

1162

–

9

.

5.

Sung

H

,

Ferlay

J

,

Siegel

RL

,

Laversanne

M

,

Soerjomataram

I

,

Jemal

A

, et al.

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

.

CA Cancer J Clin

.

2021

;

71

(

3

):

209

–

49

.

6.

Zhao

Z

,

Liu

W

.

Pancreatic cancer: a review of risk factors, diagnosis, and treatment

.

Technol Cancer Res Treat

.

2020

;

19

:

1533033820962117

.

7.

Bockhorn

M

,

Uzunoglu

FG

,

Adham

M

,

Imrie

C

,

Milicevic

M

,

Sandberg

AA

, et al.

Borderline resectable pancreatic cancer: a consensus statement by the international study group of pancreatic surgery (ISGPS)

.

Surgery

.

2014

;

155

(

6

):

977

–

88

.

8.

Oken

MM

,

Creech

RH

,

Tormey

DC

,

Horton

J

,

Davis

TE

,

McFadden

ET

, et al.

Toxicity and response criteria of the eastern cooperative Oncology group

.

Am J Clin Oncol

.

1982

;

5

(

6

):

649

–

56

.

9.

Langer

T

.

S3-Leitlinie exokrines pankreaskarzinom

.

10.

Isaji

S

,

Mizuno

S

,

Windsor

JA

,

Bassi

C

,

Fernández-Del Castillo

C

,

Hackert

T

, et al.

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

.

Pancreatology

.

2018

;

18

(

1

):

2

–

11

.

11.

Kakar

S

,

Pawlik

T

,

Allen

P

.

AJCC cancer staging manual

.

New York

:

Springer-Verlag

;

2017

.

12.

Siegel

R

,

Naishadham

D

,

Jemal

A

.

Cancer statistics, 2013

.

CA Cancer J Clin

.

2013

;

63

(

1

):

11

–

30

.

13.

Leonhardt

CS

,

Niesen

W

,

Kalkum

E

,

Klotz

R

,

Hank

T

,

Büchler

MW

, et al.

Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis

.

BJS Open

.

2022

;

6

(

2

):

zrac010

.

14.

Verbeke

CS

,

Menon

KV

.

Redefining resection margin status in pancreatic cancer

.

HPB Oxf

.

2009

;

11

(

4

):

282

–

9

.

15.

Schuhbaur

J

,

Surovtsova

I

,

Seufferlein

T

,

Kokh

D

,

Szotyori-Artz

G

,

Winzler

C

, et al.

Prognostic value of the CRM-status in pancreatic ductal adenocarcinoma - data from a regional cancer registry

.

BMC Cancer

.

2024

;

24

(

1

):

1280

.

16.

Strobel

O

,

Hank

T

,

Hinz

U

,

Bergmann

F

,

Schneider

L

,

Springfeld

C

, et al.

Pancreatic cancer surgery: the new R-status counts

.

Ann Surg

.

2017

;

265

(

3

):

565

–

73

.

17.

Conroy

T

,

Hammel

P

,

Hebbar

M

,

Ben Abdelghani

M

,

Wei

AC

,

Raoul

JL

, et al.

FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer

.

N Engl J Med

.

2018

;

379

(

25

):

2395

–

406

.

18.

Neoptolemos

JP

,

Palmer

DH

,

Ghaneh

P

,

Psarelli

EE

,

Valle

JW

,

Halloran

CM

, et al.

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

.

Lancet

.

2017

;

389

(

10073

):

1011

–

24

.

19.

Barrak

D

,

Villano

AM

,

Villafane-Ferriol

N

,

Stockton

LG

,

Hill

MV

,

Deng

M

, et al.

Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response

.

Eur J Surg Oncol

.

2022

;

48

(

6

):

1356

–

61

.

20.

Katz

MHG

,

Shi

Q

,

Meyers

J

,

Herman

JM

,

Chuong

M

,

Wolpin

BM

, et al.

Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 phase 2 randomized clinical trial

.

JAMA Oncol

.

2022

;

8

(

9

):

1263

–

70

.

21.

Ghaneh

P

,

Palmer

D

,

Cicconi

S

,

Jackson

R

,

Halloran

CM

,

Rawcliffe

C

, et al.

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

.

Lancet Gastroenterol Hepatol

.

2023

;

8

:

157

–

68

.

22.

Hackert

T

,

Sachsenmaier

M

,

Hinz

U

,

Schneider

L

,

Michalski

CW

,

Springfeld

C

, et al.

Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients

.

Ann Surg

.

2016

;

264

(

3

):

457

–

63

.

23.

Griffin

JF

,

Poruk

KE

,

Wolfgang

CL

.

Pancreatic cancer surgery: past, present, and future

.

Chin J Cancer Res

.

2015

;

27

(

4

):

332

–

48

.

24.

Jimenez

RE

,

Fernandez-del Castillo

C

,

Rattner

DW

,

Chang

Y

,

Warshaw

AL

.

Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis

.

Ann Surg

.

2000

;

231

(

3

):

293

–

300

.

25.

Traverso

LW

,

Longmire

WP

.

Preservation of the pylorus in pancreaticoduodenectomy

.

Surg Gynecol Obstet

.

1978

;

146

(

6

):

959

–

62

.

26.

Schneider

M

,

Hackert

T

,

Strobel

O

,

Büchler

MW

.

Technical advances in surgery for pancreatic cancer

.

Br J Surg

.

2021

;

108

(

7

):

777

–

85

.

27.

Sanjay

P

,

Takaori

K

,

Govil

S

,

Shrikhande

SV

,

Windsor

JA

.

Artery-first’ approaches to pancreatoduodenectomy

.

Br J Surg

.

2012

;

99

(

8

):

1027

–

35

.

28.

Ironside

N

,

Barreto

SG

,

Loveday

B

,

Shrikhande

SV

,

Windsor

JA

,

Pandanaboyana

S

.

Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival

.

Br J Surg

.

2018

;

105

(

6

):

628

–

36

.

29.

Nießen

A

,

Hackert

T

.

State-of-the-art surgery for pancreatic cancer

.

Langenbecks Arch Surg

.

2022

;

407

(

2

):

443

–

50

.

30.

Chen

X-M

,

Sun

D-L

,

Zhang

Y

.

Laparoscopic versus open pancreaticoduodenectomy combined with uncinated process approach: a comparative study evaluating perioperative outcomes (Retrospective cohort study)

.

Int J Surg

.

2018

;

51

:

170

–

3

.

31.

Hackert

T

,

Strobel

O

,

Michalski

CW

,

Mihaljevic

AL

,

Mehrabi

A

,

Müller-Stich

B

, et al.

The TRIANGLE operation – radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study

.

HPB

.

2017

;

19

(

11

):

1001

–

7

.

32.

Rosso

E

,

Zimmitti

G

,

Iannelli

A

,

Garatti

M

.

The ‘TRIANGLE operation’ by laparoscopy: radical pancreaticoduodenectomy with major vascular resection for borderline resectable pancreatic head cancer

.

Ann Surg Oncol

.

2020

;

27

(

5

):

1613

–

4

.

33.

Klotz

R

,

Hackert

T

,

Heger

P

,

Probst

P

,

Hinz

U

,

Loos

M

, et al.

The TRIANGLE operation for pancreatic head and body cancers: early postoperative outcomes

.

HPB

.

2022

;

24

(

3

):

332

–

41

.

34.

Heger

P

,

Hackert

T

,

Diener

MK

,

Feißt

M

,

Klose

C

,

Dörr-Harim

C

, et al.

Conventional partial pancreatoduodenectomy versus an extended pancreatoduodenectomy (triangle operation) for pancreatic head cancers—study protocol for the randomised controlled TRIANGLE trial

.

Trials

.

2023

;

24

(

1

):

363

.

35.

Diener

MK

,

Mihaljevic

AL

,

Strobel

O

,

Loos

M

,

Schmidt

T

,

Schneider

M

, et al.

Periarterial divestment in pancreatic cancer surgery

.

Surgery

.

2021

;

169

(

5

):

1019

–

25

.

36.

Strasberg

SM

,

Drebin

JA

,

Linehan

D

.

Radical antegrade modular pancreatosplenectomy

.

Surgery

.

2003

;

133

(

5

):

521

–

7

.

37.

Scholten

L

,

Klompmaker

S

,

Van Hilst

J

,

Annecchiarico

MM

,

Balzano

G

,

Casadei

R

, et al.

Outcomes after minimally invasive versus open total pancreatectomy: a pan-European propensity score matched study

.

Ann Surg

.

2023

;

277

(

2

):

313

–

20

.

38.

Asbun

HJ

,

Moekotte

AL

,

Vissers

FL

,

Kunzler

F

,

Cipriani

F

,

Alseidi

A

, et al.

The Miami International evidence-based guidelines on minimally invasive pancreas resection

.

Ann Surg

.

2020

;

271

:

1

–

14

.

39.

Van Hilst

J

,

De Rooij

T

,

Bosscha

K

,

Brinkman

DJ

,

van Dieren

S

,

Dijkgraaf

MG

, et al.

Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial

.

Lancet Gastroenterol Hepatol

.

2019

;

4

(

3

):

199

–

207

.

40.

Nickel

F

,

Haney

CM

,

Kowalewski

KF

,

Probst

P

,

Limen

EF

,

Kalkum

E

, et al.

Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials

.

Ann Surg

.

2020

;

271

(

1

):

54

–

66

.

41.

Müller

PC

,

Müller-Stich

BP

,

Hackert

T

,

Nickel

F

.

Robotic pancreaticoduodenectomy after the learning curve: a new hope

.

Hepatobiliary Surg Nutr

.

2022

;

11

(

3

):

489

–

91

.

42.

Xourafas

D

,

Clancy

TE

,

Swanson

RS

,

Ashley

SW

.

Comparison of perioperative outcomes between open, laparoscopic, and robotic distal pancreatectomy: an analysis of 1,815 patients from the ACS-NSQIP database

.

J Am Coll Surgeons

.

2016

;

223

(

4

):

S74

.

43.

Nickel

F

,

Studier-Fischer

A

,

Hackert

T

.

Robotische pankreaschirurgie

.

Chirurgie

.

2024

;

95

(

2

):

165

–

74

.

44.

Klotz

R

,

Mihaljevic

AL

,

Kulu

Y

,

Sander

A

,

Klose

C

,

Behnisch

R

, et al.

Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial

.

Lancet Reg Health Eur

.

2024

;

39

:

100864

.

45.

Korrel

M

,

Jones

LR

,

Van Hilst

J

,

Balzano

G

,

Björnsson

B

,

Boggi

U

, et al.

Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial

.

Lancet Reg Health Eur

.

2023

;

31

:

100673

.

46.

Uchida

Y

,

Takahara

T

,

Mizumoto

T

,

Nishimura

A

,

Mii

S

,

Iwama

H

, et al.

Technical details of robotic pancreatojejunostomy using a modified Blumgart anastomosis: thread manipulation using gauze and an assisted port

.

World J Surg

.

2024

;

48

(

7

):

1721

–

9

.

47.

Seeger

P

,

Distler

M

,

Thomaschewski

M

,

Zimmermann

M

,

Heumann

A

,

Uzunoglu

FG

, et al.

Robotische Pankreatoduodenektomie: Variationen der Pankreasanastomose in modifizierter Blumgart-Technik

.

Zentralbl Chir

.

2024

;

149

(

03

):

226

–

30

.

48.

Silber

JH

,

Rosenbaum

PR

,

Schwartz

JS

,

Ross

RN

,

Williams

SV

.

Evaluation of the complication rate as a measure of quality of care in coronary artery bypass graft surgery

.

JAMA

.

1995

;

274

(

4

):

317

–

23

.

49.

Ahola

R

,

Sand

J

,

Laukkarinen

J

.

Centralization of pancreatic surgery improves results: review

.

Scand J Surg

.

2020

;

109

(

1

):

4

–

10

.

50.

Wente

MN

,

Bassi

C

,

Dervenis

C

,

Fingerhut

A

,

Gouma

DJ

,

Izbicki

JR

, et al.

Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)

.

Surgery

.

2007

;

142

(

5

):

761

–

8

.

51.

Bassi

C

,

Dervenis

C

,

Butturini

G

,

Fingerhut

A

,

Yeo

C

,

Izbicki

J

, et al.

Postoperative pancreatic fistula: an international study group (ISGPF) definition

.

Surgery

.

2005

;

138

(

1

):

8

–

13

.

52.

Malleo

G

,

Pulvirenti

A

,

Marchegiani

G

,

Butturini

G

,

Salvia

R

,

Bassi

C

.

Diagnosis and management of postoperative pancreatic fistula

.

Langenbecks Arch Surg

.

2014

;

399

(

7

):

801

–

10

.

53.

Bassi

C

,

Marchegiani

G

,

Dervenis

C

,

Sarr

M

,

Abu Hilal

M

,

Adham

M

, et al.

The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years after

.

Surgery

.

2017

;

161

(

3

):

584

–

91

.

54.

Hackert

T

,

Werner

J

,

Büchler

MW

.

Postoperative pancreatic fistula

.

Surgeon

.

2011

;

9

(

4

):

211

–

7

.

55.

Gleeson

EM

,

Pitt

HA

,

Mackay

TM

,

Wellner

UF

,

Williamsson

C

,

Busch

OR

, et al.

Failure to rescue after pancreatoduodenectomy: a transatlantic analysis

.

Ann Surg

.

2021

;

274

(

3

):

459

–

66

.

56.

Wente

MN

,

Veit

JA

,

Bassi

C

,

Dervenis

C

,

Fingerhut

A

,

Gouma

DJ

, et al.

Postpancreatectomy hemorrhage (PPH)–An international study group of pancreatic surgery (ISGPS) definition

.

Surgery

.

2007

;

142

(

1

):

20

–

5

.

57.

Maccabe

TA

,

Robertson

HF

,

Skipworth

J

,

Rees

J

,

Roberts

K

,

Pathak

S

.

A systematic review of post-pancreatectomy haemorrhage management stratified according to ISGPS grading

.

HPB Oxf

.

2022

;

24

(

7

):

1110

–

8

.

58.

Loos

M

,

Strobel

O

,

Dietrich

M

,

Mehrabi

A

,

Ramouz

A

,

Al-Saeedi

M

, et al.

Hyperamylasemia and acute pancreatitis after pancreatoduodenectomy: two different entities

.

Surgery

.

2021

;

169

(

2

):

369

–

76

.

59.

Nentwich

MF

,

El Gammal

AT

,

Lemcke

T

,

Ghadban

T

,

Bellon

E

,

Melling

N

, et al.

Salvage completion pancreatectomies as damage control for post‐pancreatic surgery complications: a single‐center retrospective analysis

.

World J Surg

.

2015

;

39

(

6

):

1550

–

6

.

60.

Sohn

TA

,

Yeo

CJ

,

Cameron

JL

,

Geschwind

JF

,

Mitchell

SE

,

Venbrux

AC

, et al.

Pancreaticoduodenectomy: role of interventional radiologists in managing patients and complications

.

J Gastrointest Surg

.

2003

;

7

(

2

):

209

–

19

.

61.

van Veldhuisen

E

,

Klompmaker

S

,

Janssen

QP

,

Hilal

MA

,

Alseidi

A

,

Balduzzi

A

, et al.

Surgical and oncological outcomes after preoperative FOLFIRINOX chemotherapy in resected pancreatic cancer: an international multicenter cohort study

.

Ann Surg Oncol

.

2023

;

30

(

3

):

1463

–

73

.

62.

Henry

AC

,

van Dongen

JC

,

van Goor

IWJM

,

Smits

FJ

,

Nagelhout

A

,

Besselink

MG

, et al.

Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort study

.

BJS Open

.

2023

;

7

(

2

):

zrac174

.

63.

Blair

AB

,

Rosati

LM

,

Rezaee

N

,

Gemenetzis

G

,

Zheng

L

,

Hruban

RH

, et al.

Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: the impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy

.

Surgery

.

2018

;

163

(

5

):

1090

–

6

.